Evidence map›Paper›PMID 37460527›Full record

ArticleNature communications2023

Restoration of PITPNA in Type 2 diabetic human islets reverses pancreatic beta-cell dysfunction.

Yu-Te Yeh, Chandan Sona, Xin Yan, Yunxiao Li, Adrija Pathak, Mark I McDermott, Zhigang Xie, Liangwen Liu, Anoop Arunagiri, Yuting Wang and 12 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 12 institutions in 6 countries.

Yu-Te Yeh *Johns Hopkins University, All Children's Hospital, St. Petersburg, FL, 33701, USA.
Chandan Sona *Johns Hopkins University, All Children's Hospital, St. Petersburg, FL, 33701, USA.
Xin YanTranslational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology, University Medical Center Rostock, Rostock, 18147, Germany.
Yunxiao LiTranslational Neurodegeneration Section "Albrecht-Kossel", Department of Neurology, University Medical Center Rostock, Rostock, 18147, Germany.
Adrija PathakDepartment of Biochemistry & Biophysics, Texas A&M University, College Station, TX, 77843, USA.
Mark I McDermottDepartment of Cell Biology & Genetics, Texas A&M Health Science Center, College Station, TX, 77843, USA.
Zhigang XieDepartment of Cell Biology & Genetics, Texas A&M Health Science Center, College Station, TX, 77843, USA.
Liangwen LiuMedical Cell Biology, Uppsala University, 75123, Uppsala, Sweden.
Anoop ArunagiriDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, MI, 48105, USA.ORCID 0000-0001-9839-1860
Yuting WangMax Delbrück Center for Molecular Medicine, Robert Rössle Strasse 10, Berlin, 13125, Germany.
Amaury Cazenave-GassiotSingapore Lipidomics Incubator, Life Sciences Institute, National University of Singapore, 117456, Singapore, Singapore.ORCID 0000-0002-3050-634X
Adhideb GhoshLaboratory of Nutrition and Metabolic Epigenetics, Department of Health Sciences and Technology, ETH Zurich, Schwerzenbach, 8603, Switzerland.ORCID 0000-0002-5160-4571
Ferdinand von MeyennLaboratory of Nutrition and Metabolic Epigenetics, Department of Health Sciences and Technology, ETH Zurich, Schwerzenbach, 8603, Switzerland.ORCID 0000-0001-9920-3075
Sivarajan KumarasamyDepartment of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, 45701, USA.
Sonia M NajjarDepartment of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, 45701, USA.
Shiqi JiaThe First Affiliated Hospital of Jinan University, Guangzhou, China.ORCID 0000-0001-8595-9314
Markus R WenkSingapore Lipidomics Incubator, Life Sciences Institute, National University of Singapore, 117456, Singapore, Singapore.
Alexis Traynor-KaplanDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, 98195, USA.
Peter ArvanDivision of Metabolism, Endocrinology & Diabetes, University of Michigan Medical School, Ann Arbor, MI, 48105, USA.ORCID 0000-0002-4007-8799
Sebastian BargMedical Cell Biology, Uppsala University, 75123, Uppsala, Sweden.ORCID 0000-0003-4661-5724
Vytas A BankaitisDepartment of Biochemistry & Biophysics, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0002-1654-6759
Matthew N PoyJohns Hopkins University, All Children's Hospital, St. Petersburg, FL, 33701, USA. mpoy1@jhmi.edu.ORCID 0000-0002-4904-2426
Johns Hopkins University · USTexas A&M Health Science Center · USETH Zurich · CHMax Delbrück Center · DENational University of Singapore · SGOhio University · USUniversity of Michigan · USUppsala University · SEFirst Affiliated Hospital of Jinan University · CNTexas A&M University · USUniversity of Rostock · DEUniversity of Washington · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Integrated Islet Distribution Program (U24) - 2021U24DK098085 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI Carmella Evans-Molina, Joyce Carol Niland · 2021 to 2026
$17.8M
Proinsulin Trafficking for Insulin BiosynthesisR01DK048280 · NIDDK · YESHIVA UNIVERSITY · PI ARVAN, PETER · 1994 to 2024
$10.5M
The Biology and Biochemistry of Lipid Transfer Protein-Regulated Phosphoinositide SignalingR35GM131804 · NIGMS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI Vytas A Bankaitis · 2019 to 2026
$4.5M
PITPNA in pancreatic beta-cell dysfunction and diabetes pathogenesisR01DK135688 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Matthew Ng Poy · 2023 to 2026
$1.6M
NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK048280NIDDK NIH HHS R01 DK135688NIDDK NIH HHS U24 DK098085NIGMS NIH HHS R35 GM131804
6 · The paper itself

Abstract

Defects in insulin processing and granule maturation are linked to pancreatic beta-cell failure during type 2 diabetes (T2D). Phosphatidylinositol transfer protein alpha (PITPNA) stimulates activity of phosphatidylinositol (PtdIns) 4-OH kinase to produce sufficient PtdIns-4-phosphate (PtdIns-4-P) in the trans-Golgi network to promote insulin granule maturation. PITPNA in beta-cells of T2D human subjects is markedly reduced suggesting its depletion accompanies beta-cell dysfunction. Conditional deletion of Pitpna in the beta-cells of Ins-Cre, Pitpna

Indexed as

Diabetes Mellitus, Type 2Insulin-Secreting CellsIslets of LangerhansAnimalsGlucoseHumansInsulinMicePhospholipid Transfer ProteinsProinsulinGlucoseInsulinPhospholipid Transfer ProteinsPITPNA protein, humanProinsulin

Identifiers

PMID37460527
PMCPMC10352338
OpenAlexW4384559359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.